Related Experiment Video
Updated: Aug 7, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
A novel 21-kDa cytochrome c-releasing factor is generated upon treatment of human leukemia U937 cells with
Yutaka Masuda1, Sayoko Maeda, Akiko Watanabe
1Laboratory of Biological Chemistry, School of Pharmaceutical Sciences, Showa University, Tokyo, Japan.
Abstract:
Geranylgeraniol (GGO) induces apoptosis in various lines of human tumor cells through a mitochondrion-dependent pathway. The present study describes identification of a 21-kDa cytochrome c-releasing factor that appears in the cytosolic fraction after treatment of human leukemia U937 cells with GGO. Incubation of isolated mitochondria with a lysate of U937 cells that had been treated with GGO resulted in the release of cytochrome c from the mitochondria. Utilizing this cell-free system, we purified a 21-kDa protein that induced the release of cytochrome c from mitochondria and appeared to be involved in the apoptosis that is induced in U937 cells by GGO. We designated this protein cytochrome c-releasing factor 21 (CRF21). Overexpression of CRF21 in HeLa cells induced the release of cytochrome c from mitochondria, with subsequent apoptosis. Our results suggest that CRF21 might play an important role in the induction of apoptosis by GGO in leukemia U937 cells.
Insights
Geranylgeraniol (GGO) triggers cancer cell death via mitochondria. Researchers identified a key protein, cytochrome c-releasing factor 21 (CRF21), responsible for this GGO-induced apoptosis in leukemia cells.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Geranylgeraniol (GGO) is known to induce apoptosis in human tumor cells.
- The precise molecular mechanisms underlying GGO-induced apoptosis, particularly involving mitochondrial pathways, require further elucidation.
Purpose of the Study:
- To identify and characterize factors involved in GGO-induced apoptosis in human leukemia U937 cells.
- To investigate the role of a specific protein in cytochrome c release from mitochondria.
Main Methods:
- Treatment of U937 leukemia cells with GGO.
- Analysis of cytosolic fractions for protein factors.
- Cell-free system using isolated mitochondria and cell lysates.
- Protein purification and characterization.
- Overexpression studies in HeLa cells.
Main Results:
- A 21-kDa protein, designated cytochrome c-releasing factor 21 (CRF21), was identified in the cytosolic fraction of GGO-treated U937 cells.
- CRF21 was found to induce the release of cytochrome c from isolated mitochondria.
- Overexpression of CRF21 in HeLa cells led to cytochrome c release and subsequent apoptosis.
- CRF21 appears to be a key mediator of GGO-induced apoptosis.
Conclusions:
- CRF21 is a novel protein that induces cytochrome c release from mitochondria.
- CRF21 plays a significant role in the GGO-induced apoptotic pathway in leukemia U937 cells.
- CRF21 may represent a therapeutic target for GGO-based cancer treatments.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells
